Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 174

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis

Open access
Soeroto, Arto Yuwono, Soetedjo, Nanny Natalia, Purwiga, Aga, Santoso, Prayudi, Kulsum, Iceu Dimas, Suryadinata, Hendarsyah, Ferdian, Ferdy · 2020 · Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Abstract

Background and aims Corona virus diseases 2019 (COVID-19) pandemic spread rapidly. Growing evidences that overweight and obesity which extent nearly a third of the world population were associated with severe COVID-19. This study aimed to explore the association and risk of increased BMI and obesity with composite poor outcome in COVID-19 adult patients. Methods We conducted a systematic literature search from PubMed and Embase database. We included all original research articles in COVID-19 adult patients and obesity based on classification of Body Mass Index (BMI) and composite poor outcome which consist of ICU admission, ARDS, severe COVID-19, use of mechanical ventilation, hospital admission, and mortality. Results Sixteen studies were included in meta-analysis with 9 studies presented BMI as continuous outcome and 10 studies presented BMI as dichotomous outcome (cut-off ≥30 kg/m2). COVID-19 patients with composite poor outcome had higher BMI with mean difference 1.12 (95% CI, 0.67–1.57, P < 0.001). Meanwhile, obesity was associated with composite poor outcome with odds ratio (OR) = 1.78 (95% CI, 1.25–2.54, P < 0.001) Multivariate meta-regression showed the association between BMI and obesity on composite poor outcome were affected by age, gender, DM type 2, and hypertension. Conclusion Obesity is a risk factor of composite poor outcome of COVID-19. On the other hand, COVID-19 patients with composite poor outcome have higher BMI. BMI is an important routine procedure that should always be assessed in the management of COVID-19 patients and special attention should be given to patients with obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.dsx.2020.09.029

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 37

  1. Kruglikov, 2020, The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections, Obesity, 28, 1187, 10.1002/oby.22856 · DOI · Paper page
  2. Ge, 2020, The epidemiology and clinical information about COVID-19, Eur J Clin Microbiol Infect Dis, 1
  3. Guo, 2020, The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status, Mil Med Res, 7, 11
  4. Kulcsar, 2019, Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection, JCI Insight, 4, 10.1172/jci.insight.131774 · DOI · Paper page
  5. Chooi, 2019, The epidemiology of obesity, Metab Clin Exp, 92, 6, 10.1016/j.metabol.2018.09.005 · DOI · Paper page
  6. Michalakis, 2013, Obesity in the ageing man, Metab Clin Exp, 62, 1341, 10.1016/j.metabol.2013.05.019 · DOI
  7. Hu, 2018, Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication, Diabetes, 67, 3, 10.2337/dbi17-0013 · DOI · Paper page
  8. Colaneri, 2020, Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, Euro Surveill Bull Eur Sur Les Maladies Transmissibles = Eur Commun Dis Bull, 25
  9. Huang, 2020, Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression, Diabetes & metabolic syndrome, 14, 395, 10.1016/j.dsx.2020.04.018 · DOI · Paper page
  10. Guan, 2020, Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis, Eur Respir J, 55, 10.1183/13993003.00547-2020 · DOI · Paper page
  11. Kimura, 2020, Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells, J Allergy Clin Immunol, 146, 80, 10.1016/j.jaci.2020.05.004 · DOI · Paper page
  12. Zapater, 2004, Gender differences in angiotensin-converting enzyme (ACE) activity and inhibition by enalaprilat in healthy volunteers, J Cardiovasc Pharmacol, 43, 737, 10.1097/00005344-200405000-00018 · DOI
  13. Komukai, 2010, Gender and the renin–angiotensin–aldosterone system, Fund Clin Pharmacol, 24, 687, 10.1111/j.1472-8206.2010.00854.x · DOI · Paper page
  14. Moser, 2019, Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses, Influenza Respir Viruses, 13, 3, 10.1111/irv.12618 · DOI · Paper page
  15. Honce, 2019, Impact of obesity on influenza A virus pathogenesis, immune response, and evolution, Front Immunol, 10, 1071, 10.3389/fimmu.2019.01071 · DOI · Paper page
  16. Severin, 2020, Respiratory muscle performance screening for infectious disease management following COVID-19: a highly pressurized situation, Am J Med, 133, 1025, 10.1016/j.amjmed.2020.04.003 · DOI
  17. Sood, 2009, Altered resting and exercise respiratory physiology in obesity, Clin Chest Med, 30, 445, 10.1016/j.ccm.2009.05.003 · DOI
  18. Moon, 2019, The influence of morbid obesity on difficult intubation and difficult mask ventilation, J Anesth, 33, 96
  19. Frasca, 2019, Influence of obesity on pneumococcus infection risk in the elderly, Front Endocrinol, 10, 71, 10.3389/fendo.2019.00071 · DOI
  20. Coelho, 2013, Biochemistry of adipose tissue: an endocrine organ, Arch Med Sci : AMS, 9, 191, 10.5114/aoms.2013.33181 · DOI · Paper page
  21. Hibbert, 2012, Obesity and ARDS, Chest, 142, 785, 10.1378/chest.12-0117 · DOI
  22. Siddiqi, 2020, COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal, J Heart Lung Transplant Off Publ Int Soc Heart Transplantation, 39, 405, 10.1016/j.healun.2020.03.012 · DOI · Paper page
  23. Argenziano, 2020, Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series, BMJ, 369, m1996, 10.1136/bmj.m1996 · DOI · Paper page
  24. Dreher, 2020, The characteristics of 50 hospitalized COVID-19 patients with and without ARDS, Deutsches Arzteblatt Int, 117, 271
  25. Gregoriano, 2020, Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: an observational analysis, Swiss Med Wkly, 150, w20316, 10.4414/smw.2020.20316 · DOI
  26. Hur, 2020, Factors associated with intubation and prolonged intubation in hospitalized patients with COVID-19, Otolaryngol--Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg, 163, 170, 10.1177/0194599820929640 · DOI · Paper page
  27. Kalligeros, 2020, Association of obesity with disease severity among patients with coronavirus disease 2019, Obesity, 28, 1200, 10.1002/oby.22859 · DOI · Paper page
  28. Ortiz-Brizuela, 2020, Clinical and epidemiological characteristics OF patients diagnosed with COVID-19 IN a tertiary care center IN Mexico city: a prospective cohort study, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 72, 165
  29. Petrilli, 2020, Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study, BMJ, 369, m1966, 10.1136/bmj.m1966 · DOI · Paper page
  30. Simonnet, 2020, High prevalence of obesity in severe acute respiratory Syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation, Obesity, 28, 1195, 10.1002/oby.22831 · DOI · Paper page
  31. Suleyman, 2020, Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan detroit, JAMA network open, 3, 10.1001/jamanetworkopen.2020.12270 · DOI · Paper page
  32. Yu, 2020, Association between clinical manifestations and prognosis in patients with COVID-19, Clin Therapeut, 42, 964, 10.1016/j.clinthera.2020.04.009 · DOI
  33. Cao, 2020, Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China, Clinical Infect Dis, 10.1093/cid/ciaa243 · DOI · Paper page
  34. Chen, 2020, Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China, Infection, 1
  35. Basta, 2020, It’s world war at CoViD-19. The first battle on the front of the viral invasion against the exitus for interstitial pneumonia was decisive, Recenti Prog Med, 111, 238
  36. Hu, 2020, Risk factors associated with clinical outcomes in 323 COVID-19 hospitalized patients in Wuhan, China, Clinical Infect Dis Official Publ Infect Dise Soc Am
  37. Memtsoudis, 2020, Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea, Br J Addiction: Br J Anaesth, 125, e262

Cited by

See all 174

Metadata

Authors
Soeroto, A. Y., Soetedjo, N. N., Purwiga, A., Santoso, P., Kulsum, I. D., Suryadinata, H., & Ferdian, F.
Venue
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Publisher
Elsevier BV
Published
2020-11
Volume
14
Issue
6
Pages
1897-1904
ISSN
1871-4021 (ISSN-L)
OpenAlex
W3088166068
Cited by
174
References
4
FWCI
1.98
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1016/j.dsx.2020.09.029
The paper
Soeroto, A. Y., Soetedjo, N. N., Purwiga, A., Santoso, P., Kulsum, I. D., Suryadinata, H., & Ferdian, F. (2020). Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. https://doi.org/10.1016/j.dsx.2020.09.029

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.